Production of a novel influenza vaccine using insect cells: protection against drifted strains

A recombinant trivalent hemagglutinin (HA) vaccine produced in cell culture using the baculovirus expression system provides an attractive alternative to the current egg‐based influenza vaccine (Trivalent Inactivated Influenza Vaccine [TIV]) manufacturing process. The HA genes from the annual World...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Manon M. J., Karl Anderson, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634664/
https://www.ncbi.nlm.nih.gov/pubmed/19453478
http://dx.doi.org/10.1111/j.1750-2659.2006.00007.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634664/
https://www.ncbi.nlm.nih.gov/pubmed/19453478
http://dx.doi.org/10.1111/j.1750-2659.2006.00007.x

Ejemplares similares